{"id":2286,"date":"2025-01-06T14:56:00","date_gmt":"2025-01-06T11:56:00","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2286"},"modified":"2025-03-07T15:30:18","modified_gmt":"2025-03-07T12:30:18","slug":"santhera-enters-into-supply-and-distribution-agreement-for-agamree-vamorolone-with-clinigen-group","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/santhera-enters-into-supply-and-distribution-agreement-for-agamree-vamorolone-with-clinigen-group\/","title":{"rendered":"Santhera conclut un accord de fourniture et de distribution d&#039;AGAMREE (Vamorolone) avec le groupe Clinigen"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Santhera Pharmaceuticals annonce la signature d&#039;un accord exclusif avec Clinigen Group pour g\u00e9rer l&#039;approvisionnement et la distribution d&#039;AGAMREE\u00ae (vamorolone) dans les pays o\u00f9 le produit n&#039;est pas autrement disponible dans le commerce.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Santhera Pharmaceuticals et Clinigen Group annoncent avoir sign\u00e9 un accord d&#039;approvisionnement et de distribution pour AGAMREE dans les pays o\u00f9 le produit ne peut actuellement pas \u00eatre obtenu commercialement via Santhera ou l&#039;un de ses partenaires de distribution actuels.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L&#039;accord permettra l&#039;acc\u00e8s \u00e0 AGAMREE au cas par cas pour les patients atteints de dystrophie musculaire de Duchenne (DMD) dans les situations o\u00f9 le m\u00e9decin traitant estime qu&#039;il n&#039;existe pas d&#039;alternative appropri\u00e9e et o\u00f9 la r\u00e9glementation le permet. Cet accord permet \u00e0 Santhera de recevoir la majorit\u00e9 des revenus g\u00e9n\u00e9r\u00e9s par la fourniture du produit dans ces pays suppl\u00e9mentaires.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.santhera.com\/assets\/files\/press-releases\/2025-01-06-Santhera_Clinigen_e-FINAL.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">En savoir plus<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE\u00ae (vamorolone) in countries where the product is not otherwise commercially available. Santhera Pharmaceuticals and Clinigen Group announce that they have signed a Supply and Distribution Agreement for AGAMREE in countries where the product can currently [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,111,41,43],"class_list":["post-2286","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-clinigen-group","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=2286"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/2287"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=2286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=2286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=2286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}